SARA MORILLO: Open Payments
NPI 1528541166 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,106 in 79 payments from 19 companies in 2025. Trend: 2023 $3,096 · 2024 $3,181 · 2025 $2,106
Food & beverage: $1,946Education: $160
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 11 | $262 |
| Janssen Biotech, Inc. | 7 | $237 |
| Amgen Inc. | 9 | $225 |
| Janssen Scientific Affairs, LLC | 2 | $186 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $177 |
| Lilly USA, LLC | 3 | $162 |
| Regeneron Healthcare Solutions, Inc. | 5 | $142 |
| Organon LLC | 7 | $141 |
| PFIZER INC. | 10 | $139 |
| Botanix SB Inc | 5 | $87 |
Products named: TREMFYA, OTEZLA, DUPIXENT, CIBINQO, SOFDRA, Rhapsido, COSENTYX, Zoryve.
Industry payments across FL — which companies pay providers there.
